Contrast Media Injectors Market Size, Share, Trends, Industry Analysis Report: By Product (Injector Systems, Consumables, and Accessories), Type, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025 – 2034
- Published Date:Nov-2024
- Pages: 120
- Format: PDF
- Report ID: PM5228
- Base Year: 2024
- Historical Data: 2020-2023
Contrast Media Injectors Market Overview
Global contrast media injectors market size was valued at USD 1,575.29 million in 2024. The market is projected to grow from USD 1,695.49 million in 2025 to USD 3,327.65 million by 2034, exhibiting a CAGR of 7.8% during the forecast period.
Contrast media injectors are specialized medical devices used to administer contrast agents into a patient's bloodstream during imaging procedures, such as computed tomography (CT) or magnetic resonance imaging (MRI). The increasing prevalence of chronic diseases fuels the growth of the contrast media injectors market. Globally, the large population suffers from several types of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders. For instance, according to the WHO, cardiovascular diseases are responsible for the majority of non-communicable disease (NCD) deaths, accounting for 17.9 million fatalities annually, which are followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million). These chronic diseases require detailed imaging for accurate diagnosis, treatment planning, and monitoring of disease progression. Advanced imaging techniques, such as CT and MRI, use contrast media to enhance the visibility of internal structures and abnormalities.
To Understand More About this Research: Request a Free Sample Report
As a result, the demand for contrast media injectors is increasing because they are crucial for delivering the right amount of contrast agents needed for clear imaging. This rise in demand for diagnostic imaging and better disease management is fueling the growth of the contrast media injectors market.
Agreements between major companies to supply contrast media ingredients are strongly boosting the contrast media injectors market by making sure there is a constant and reliable supply of the key components needed for imaging procedures. For instance, in October 2022, GE Healthcare's Pharmaceutical Diagnostics division entered into a long-term agreement with SQM (Sociedad Quimica y Minera de Chile S.A.), a Chile-based mining company, to ensure a stable supply of iodine, a critical component in contrast media products utilized in X-ray and Computed Tomography procedures worldwide. Such agreements assist in stabilizing supply chains, reducing production costs, and improving the availability of high-quality contrast agents, which in turn supports the effective use of contrast media injectors in diagnostic imaging. Thus, the contrast media injectors market is growing because of these collaborations that benefit the market by enhanced product consistency.
Contrast Media Injectors Market Drivers and Trends
Advanced Product Launches
Manufacturers are introducing innovative technologies and features that enhance the performance, safety, and efficiency of imaging procedures. Newer models of contrast media injectors incorporate advancements such as automated workflows, improved precision in contrast delivery, and enhanced integration with imaging systems. For instance, in August 2024, Bayer launched the MEDRAD Stellant FLEX Computed Tomography Injection System, which incorporates Bayer's advanced CT injection technology and features a user-centric design. The Stellant FLEX system leverages automation to execute customized patient protocols and personalized imaging, while also requiring minimal technologist training. These types of technological upgrades address evolving clinical needs and offer reliable patient outcomes. Therefore, the introduction of advanced contrast media injectors is stimulating market growth by meeting demands for technology-based imaging technology.
Increasing Adoption and Installation of CT Injection Systems
The increasing adoption and installation of CT injection systems are propelling the contrast media injectors market by driving demand for specialized equipment that enhances the effectiveness of computed tomography (CT) imaging. The need for compatible contrast media injectors is growing as CT scanners have become more prevalent in medical facilities due to their diagnostic precision and versatility. Several hospitals and health centers are adopting these CT injection systems. For instance, in November 2022, Sunnybrook Health Sciences Centre and Bayer announced the launch and installation of the MEDRAD Centargo CT Injection System, a new innovative injector from Bayer for computed tomography (CT). Such adoption of CT imaging capabilities in both clinical and outpatient establishments fuels the demand for advanced injectors, thereby accelerating contrast media injectors market growth.
Contrast Media Injectors Market Segment Insights
Contrast Media Injectors Market Breakdown by Offering Insights
The global contrast media injectors market segmentation, based on offering, includes injector systems, consumables, and accessories. The consumables segment in the market is projected to register a significant CAGR due to the recurring need for contrast media and related materials in imaging procedures. Consumables such as tubings and syringes are essential for the operation of contrast media injectors and are used on a per-procedure basis. The demand for these consumables is growing as the frequency of diagnostic imaging procedures is rising with the increasing prevalence of chronic diseases and advancements in imaging technology.
Contrast Media Injectors Application Insights
The global contrast media injectors market segmentation, based on application, includes interventional cardiology, interventional radiology, and radiology. In 2024, the radiology segment held the largest revenue share of the market due to the widespread and essential use of contrast media in diagnostic imaging procedures performed in radiology. Radiology departments are key users of contrast media injectors, as they rely on advanced imaging techniques such as CT scans, MRIs, and angiographies to diagnose and monitor a wide range of medical conditions. The high volume of imaging procedures conducted in radiology, along with the need for precise contrast administration to enhance image clarity and diagnostic accuracy, drives substantial demand for contrast media injectors in radiology.
Contrast Media Injectors Regional Insights
By region, the study provides the contrast media injectors market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest revenue share in the global market due to its well-established healthcare industry. The region boasts a robust network of hospitals, diagnostic centers, and research institutions that frequently utilize contrast media injectors for high-resolution imaging across a variety of medical specialties. Also, there is a significant increase in healthcare expenditure due to the presence of advanced medical technology. For instance, according to the Centers for Medicare & Medicaid Services, national health expenditures (NHE) experienced a 4.1% growth, reaching USD 4.5 trillion, which represented USD 13,493 per person in 2022. Such significant growth in healthcare expenditure ensures a high demand for imaging solutions, including contrast media injectors.
The US held a significant market share of the North America contrast media injectors market due to the increasing number of agreements and partnerships between firms to offer these injectors in the country. For instance, in November 2022, GE HealthCare announced a partnership with Ulrich Medical to introduce a contrast media injector in the United States. These types of agreements facilitate the distribution and integration of advanced injectors into medical practices across the country.
Asia Pacific contrast media injectors market is expected to grow with a substantial CAGR during the forecast period due to the rising prevalence of chronic diseases and non-communicable diseases such as cancer and cardiovascular conditions in the region. There is an increased need for advanced diagnostic tools and imaging techniques to manage and treat these conditions effectively. Therefore, the growing need for contrast media injectors is anticipated to drive the market in the region, as contrast media injectors enhance the quality of diagnostic imaging and provide precise assessments of disease progression.
Contrast Media Injectors Key Market Players & Competitive Insights
The contrast media injectors market is highly competitive, with key players dominating the industry. The companies differentiate themselves through innovation, strategic partnerships, and geographical expansion. Major firms emphasize offering advanced contrast media injectors with innovative technology, competing on product features, reliability, and integration with imaging systems.
The market competitiveness is intensified by emerging players and regional companies offering cost-effective solutions tailored to specific regional needs. Ongoing research and development activities aim to enhance injector efficiency, safety, and patient comfort, driving continuous technological advancements and benefiting healthcare providers and end-users with improved diagnostic capabilities. Major players in the contrast media injectors market include APOLLO RT Co. Ltd.; Bayer, Bracco; GE HealthCare; Guerbet; Leriva; MEDTRON AG; Nemoto Kyorindo Co., Ltd; SINO MDT; Spectrum Medical Technologies LLP; ulrich GmbH & Co. KG; and Vygon Group.
Bayer is a multinational company that specializes in life sciences, encompassing healthcare and agriculture. The company's pharmaceutical division researches, develops, and manufactures innovative medicines to prevent, treat, and cure many diseases. This segment includes cardiology, oncology, neurology, and women's health. In addition, Bayer's consumer health division offers a variety of over-the-counter products that promote personal well-being and health. Bayer's crop science division provides farmers with tools and technologies to enhance crop yields while optimizing land, water, and energy resources. It encompasses the development of agricultural biologicals, crop protection solutions, and digital farming technologies that enable more efficient and sustainable agricultural practices. In September 2023, Bayer and Hologic Inc. formed a partnership aimed at providing contrast-enhanced mammography (CEM) solutions to enhance the detection of breast cancer among women in various countries in the European and Asia Pacific regions.
ulrich GmbH & Co. KG is a medical technology company based in Germany that specializes in the fields of radiology and spinal surgery. The company delivers medical devices and equipment that enhance patient care and improve clinical outcomes. The company's product offerings include advanced imaging solutions, such as radiographic systems and accessories that support precise diagnostics and treatment planning in radiology. In spinal surgery, the company provides a comprehensive range of surgical instruments and implants designed to facilitate minimally invasive procedures and enhance surgical precision. In August 2024, ulrich GmbH & Co. KG and Bracco entered into a new long-term partnership to introduce an advanced MR injector under a private label agreement exclusively in the United States.
List of Key Companies in Contrast Media Injectors Market
- APOLLO RT Co. Ltd.
- Bayer
- Bracco
- GE HealthCare
- Guerbet
- Leriva
- MEDTRON AG
- Nemoto Kyorindo Co., Ltd
- SINO MDT
- Spectrum Medical Technologies LLP
- ulrich GmbH & Co. KG
- Vygon Group
Contrast Media Injectors Industry Developments
June 2019: Nottingham University Hospital NHS Trust (NUH) has upgraded its CT department with Ulrich CT Motion contrast injectors, replacing all existing injectors. A total of five injectors have been installed, with two located at the City Hospital site and three at Queen’s Medical Centre.
November 2019: Leriva extended its collaboration with the Bracco Group to offer its wide range of contrast media agents covering various diagnostic imaging modalities, such as Iomeron and Iopamiro, Multihance, and Sonovue, and to market the Bracco Injeneering contrast injectors and their associated consumables.
July 2023: GE HealthCare introduced Pixxoscan, a macrocyclic, non-ionic gadolinium-based contrast agent for Magnetic Resonance Imaging (MRI). This launch enhances GE HealthCare’s range of MRI contrast agents, providing customers with two top macrocyclic molecules, including Pixxoscan (gadobutrol) and Clariscan (gadoteric acid).
Contrast Media Injectors Market Segmentation
By Product Outlook
- Injector Systems
- CT Injector Systems
- MRI Injector Systems
- Cardiovascular/Angiography Injector Systems
- Consumables
- Tubing
- Syringe
- Others
- Accessories
By Type Outlook
- Dual-head Injectors
- Single-head Injectors
- Syringeless Injectors
By Application Outlook
- Interventional Cardiology
- Interventional Radiology
- Radiology
By End User Outlook
- Ambulatory Surgery Centers
- Diagnostics Centers
- Hospitals
By Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Contrast Media Injectors Report Scope
|
Report Attributes |
Details |
|
Market Size Value in 2024 |
USD 1,575.29 Million |
|
Market Size Value in 2025 |
USD 1,695.49 Million |
|
Revenue Forecast in 2034 |
USD 3,327.65 Million |
|
CAGR |
7.8% from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2020 – 2023 |
|
Forecast Period |
2025 – 2034 |
|
Quantitative Units |
Revenue in USD million and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
FAQ's
The global contrast media injectors market size was valued at USD 1,575.29 million in 2024 and is projected to grow to USD 3,327.65 million by 2034
The global market is projected to exhibit a CAGR of 7.8% during the forecast period, 2025-2034.
North America had the largest share in the global market
The key players in the market are APOLLO RT Co. Ltd.; Bayer, Bracco; GE HealthCare; Guerbet; Leriva; MEDTRON AG; Nemoto Kyorindo Co., Ltd; SINO MDT; Spectrum Medical Technologies LLP; ulrich GmbH & Co. KG; and Vygon Group.
The consumables segment in the market is expected to grow with a substantial CAGR due to the ongoing demand for contrast media and associated materials during imaging procedures.
In 2024, the radiology sector dominated the contrast media injectors market in terms of revenue because of the widespread application of contrast media in diagnostic imaging procedures within the field of radiology.
© 2024 Polaris Market Research and Consulting. All rights reserved
